Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 703653, 12 pages
http://dx.doi.org/10.1155/2014/703653
Research Article

Monocyte Subsets in Schistosomiasis Patients with Periportal Fibrosis

1Serviço de Imunologia, Complexo Hospitalar Universitário Professor Edgard Santos, Universidade Federal da Bahia, Rua João das Botas s/n, Canela, 40110-160 Salvador, BA, Brazil
2Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT), CNPQ/MCT, Brazil
3Escola Bahiana de Medicina e Saúde Pública, 40050-420 Salvador, BA, Brazil
4Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, UFBA, 40170-115 Salvador, BA, Brazil

Received 25 September 2013; Revised 16 January 2014; Accepted 30 January 2014; Published 13 March 2014

Academic Editor: Dennis Daniel Taub

Copyright © 2014 Jamille Souza Fernandes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Iarotski and A. Davis, “The schistosomiasis problem in the world: results of a WHO questionnaire survey,” Bulletin of the World Health Organization, vol. 59, no. 1, pp. 115–127, 1981. View at Google Scholar · View at Scopus
  2. P. Steinmann, J. Keiser, R. Bos, M. Tanner, and J. Utzinger, “Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk,” The Lancet Infectious Diseases, vol. 6, no. 7, pp. 411–425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. “Vigilância Epidemiológica e Controle da Esquistossomose,” 2007, ftp://ftp.cve.saude.sp.gov.br/doc_tec/hidrica/doc/manu_esqui.pdf.
  4. BRASIL, “Guia de Vigilância Epidemiológica,” 2009.
  5. K. S. Warren, “Pathophysiology and pathogenesis of hepatosplenic schistosomiasis mansoni,” Bulletin of the New York Academy of Medicine, vol. 44, no. 3, pp. 280–294, 1968. View at Google Scholar · View at Scopus
  6. I. Bica, D. H. Hamer, and M. J. Stadecker, “Hepatic schistosomiasis,” Infectious Disease Clinics of North America, vol. 14, no. 3, pp. 583–604, 2000. View at Google Scholar · View at Scopus
  7. M. G. Chiaramonte, M. Mentink-Kane, B. A. Jacobson et al., “Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2-dominant immune response,” Journal of Experimental Medicine, vol. 197, no. 6, pp. 687–701, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Baptista and Z. A. Andrade, “Angiogenesis and schistosomal granuloma formation,” Memorias do Instituto Oswaldo Cruz, vol. 100, no. 2, pp. 183–185, 2005. View at Google Scholar · View at Scopus
  9. T. A. Wynn, “Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 524–529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Henri, C. Chevillard, A. Mergani et al., “Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-γ is associated with protection against fibrosis and TNF-α with aggravation of disease,” Journal of Immunology, vol. 169, no. 2, pp. 929–936, 2002. View at Google Scholar · View at Scopus
  11. J. C. Bina and A. Prata, “Schistosomiasis in hyperendemic area of Taquarendi. I: Schistosoma mansoni infection and severe clinikal forms,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 36, no. 2, pp. 211–216, 2003. View at Google Scholar · View at Scopus
  12. F. Marra, S. Aleffi, S. Galastri, and A. Provenzano, “Mononuclear cells in liver fibrosis,” Seminars in Immunopathology, vol. 31, no. 3, pp. 345–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe et al., “Nomenclature of monocytes and dendritic cells in blood,” Blood, vol. 116, no. 16, pp. e74–e80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Liaskou, H. W. Zimmermann, K. K. Li et al., “Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics,” Hepatology, vol. 57, no. 1, pp. 385–398, 2013. View at Google Scholar
  16. A. M. Bafica, L. S. Cardoso, S. C. Oliveira et al., “Changes in T-cell and monocyte phenotypes in vitro by Schistosoma mansoni antigens in cutaneous leishmaniasis patients,” Journal of Parasitology Research, vol. 2012, Article ID 520308, 2012. View at Publisher · View at Google Scholar
  17. N. Katz, P. M. Coelho, and J. Pellegrino, “Evaluation of Kato's quantitative method through the recovery of Schistosoma mansoni eggs added to human feces,” Journal of Parasitology, vol. 56, no. 5, pp. 1032–1033, 1970. View at Google Scholar · View at Scopus
  18. R. P. de Souza, L. S. Cardoso, G. T. Lopes et al., “Cytokine and chemokine profile in individuals with different degrees of periportal fibrosis due to Schistosoma mansoni infection,” Journal of Parasitology Research, vol. 2012, Article ID 394981, 2012. View at Publisher · View at Google Scholar
  19. M. F. Abdel-Wahab, G. Esmat, A. Farrag, Y. A. El-Boraey, and G. T. Strickland, “Grading of hepatic schistosomiasis by the use of ultrasonography,” The American Journal of Tropical Medicine and Hygiene, vol. 46, no. 4, pp. 403–408, 1992. View at Google Scholar · View at Scopus
  20. A. R. De Jesus, A. Magalhães, D. Gonzalez Miranda et al., “Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection,” Infection and Immunity, vol. 72, no. 6, pp. 3391–3397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. F. Alves Oliveira, E. C. Moreno, G. Gazzinelli et al., “Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans,” Infection and Immunity, vol. 74, no. 2, pp. 1215–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Booth, J. K. Mwatha, S. Joseph et al., “Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-γ, high TNF-α, or low RANTES, depending on age and gender,” Journal of Immunology, vol. 172, no. 2, pp. 1295–1303, 2004. View at Google Scholar · View at Scopus
  23. R. R. Oliveira, K. J. Gollob, J. P. Figueiredo et al., “Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma,” Microbes and Infection, vol. 11, no. 2, pp. 223–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. N. Silva-Teixeira, C. Contigli, J. R. Lambertucci, J. C. Serufo, and V. Rodrigues Jr., “Gender-related cytokine patterns in sera of schistosomiasis patients with symmers' fibrosis,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 3, pp. 627–630, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Mohamed-Ali, N.-E. M. A. Elwali, A. A. Abdelhameed et al., “Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression,” Journal of Infectious Diseases, vol. 180, no. 4, pp. 1298–1306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Houston, M. Munjoma, K. Kanyimo, R. N. Davidson, and G. Flowerdew, “Use of ultrasound in a study of schistosomal periportal fibrosis in rural Zimbabwe,” Acta Tropica, vol. 53, no. 1, pp. 51–58, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Abdel-Wahab, G. Esmat, M. Milad, S. Abdel-Razek, and G. T. Strickland, “Characteristic sonographic pattern of schistosomal hepatic fibrosis,” The American Journal of Tropical Medicine and Hygiene, vol. 40, no. 1, pp. 72–76, 1989. View at Google Scholar · View at Scopus
  28. J. Richter, E. da Silva Monteiro, R. Moreira Braz et al., “Sonographic organometry in Brazilian and Sudanese patients with hepatosplenic schistosomiasis mansoni and its relation to the risk of bleeding from oesophageal varices,” Acta Tropica, vol. 51, no. 3-4, pp. 281–290, 1992. View at Google Scholar · View at Scopus
  29. M. Homeida, S. Ahmed, A. Dafalla et al., “Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan,” The American Journal of Tropical Medicine and Hygiene, vol. 39, no. 2, pp. 196–201, 1988. View at Google Scholar · View at Scopus
  30. A. R. De Jesus, D. Gonzalez Miranda, R. Gonzalez Miranda et al., “Morbidity associated with Schistosoma mansoni infection determined by ultrasound in an endemic area of Brazil, Caatinga do Moura,” The American Journal of Tropical Medicine and Hygiene, vol. 63, no. 1-2, pp. 1–4, 2000. View at Google Scholar · View at Scopus
  31. J. S. Duffield, S. J. Forbes, C. M. Constandinou et al., “Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair,” Journal of Clinical Investigation, vol. 115, no. 1, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. K. R. Karlmark, R. Weiskirchen, H. W. Zimmermann et al., “Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis,” Hepatology, vol. 50, no. 1, pp. 261–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Mitchell, D. Couton, J.-P. Couty et al., “Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice,” The American Journal of Pathology, vol. 174, no. 5, pp. 1766–1775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Seki, S. De Minicis, S. Inokuchi et al., “CCR2 promotes hepatic fibrosis in mice,” Hepatology, vol. 50, no. 1, pp. 185–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. K. L. Wong, J. J.-Y. Tai, W.-C. Wong et al., “Gene expression profiling reveals the defining features of the classical, intermediate,and nonclassical human monocyte subsets,” Blood, vol. 118, no. 5, pp. e16–e31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Cros, N. Cagnard, K. Woollard et al., “Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors,” Immunity, vol. 33, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Hudig, K. W. Hunter, W. J. Diamond, and D. Redelman, “Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals,” Cytometry B, 2013. View at Publisher · View at Google Scholar
  38. F. L. van de Veerdonk and M. G. Netea, “Diversity: a hallmark of monocyte society,” Immunity, vol. 33, no. 3, pp. 289–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hesse, M. Modolell, A. C. La Flamme et al., “Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism,” Journal of Immunology, vol. 167, no. 11, pp. 6533–6544, 2001. View at Google Scholar · View at Scopus
  40. D. R. Herbert, C. Hölscher, M. Mohrs et al., “Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology,” Immunity, vol. 20, no. 5, pp. 623–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Jankovic, M. C. Kullberg, N. Noben-Trauth et al., “Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile,” Journal of Immunology, vol. 163, no. 1, pp. 337–342, 1999. View at Google Scholar · View at Scopus
  42. F. Verrecchia and A. Mauviel, “Transforming growth factor-β and fibrosis,” World Journal of Gastroenterology, vol. 13, no. 22, pp. 3056–3062, 2007. View at Google Scholar · View at Scopus
  43. A. Fine and R. H. Goldstein, “The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts,” Journal of Biological Chemistry, vol. 262, no. 8, pp. 3897–3902, 1987. View at Google Scholar · View at Scopus
  44. W. A. Border and N. A. Noble, “Transforming growth factor β in tissue fibrosis,” The New England Journal of Medicine, vol. 331, no. 19, pp. 1286–1292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Kanzler, M. Baumann, P. Schirmacher et al., “Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β,” Journal of Viral Hepatitis, vol. 8, no. 6, pp. 430–437, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Li, L. E. Vriend, I. A. Nasser et al., “Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis,” Hepatology, vol. 56, no. 6, pp. 2094–2105, 2012. View at Google Scholar
  47. R. M. A. Khalil, L. Hültner, R. Mailhammer et al., “Kinetics of interleukin-6 production after experimental infection of mice with Schistosoma mansoni,” Immunology, vol. 89, no. 2, pp. 256–261, 1996. View at Google Scholar · View at Scopus
  48. S. W. Chensue, K. Warmington, J. Ruth, P. Lincoln, M.-C. Kuo, and S. L. Kunkel, “Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor,” The American Journal of Pathology, vol. 145, no. 5, pp. 1105–1113, 1994. View at Google Scholar · View at Scopus
  49. M. R. Duncan and B. Berman, “Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6,” Journal of Investigative Dermatology, vol. 97, no. 4, pp. 686–692, 1991. View at Google Scholar · View at Scopus
  50. M. Lotz and P.-A. Guerne, “Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA),” Journal of Biological Chemistry, vol. 266, no. 4, pp. 2017–2020, 1991. View at Google Scholar · View at Scopus
  51. M. Mihara, Y. Moriya, and Y. Ohsugi, “IL-6-soluble IL-6 receptor complex inhibits the proliferation of dermal fibroblasts,” International Journal of Immunopharmacology, vol. 18, no. 1, pp. 89–94, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. T. C. Barnes, M. E. Anderson, and R. J. Moots, “The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis,” International Journal of Rheumatology, vol. 2011, Article ID 721608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Fuster, J. I. Tsui, D. M. Cheng et al., “Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems,” AIDS Research and Human Retroviruses, vol. 29, no. 8, pp. 1110–1116, 2013. View at Google Scholar
  54. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. P. R. Mangan, L. E. Harrington, D. B. O'Quinn et al., “Transforming growth factor-β induces development of the T H17 lineage,” Nature, vol. 441, no. 7090, pp. 231–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Google Scholar
  58. H. Tallima, M. Salah, F. R. Guirguis, and R. El Ridi, “Transforming growth factor-β and Th17 responses in resistance to primary murine schistosomiasis mansoni,” Cytokine, vol. 48, no. 3, pp. 239–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. A. Andrade, “Schistosomiasis and liver fibrosis: review article,” Parasite Immunology, vol. 31, no. 11, pp. 656–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. L. I. Rutitzky, J. R. Lopes da Rosa, and M. J. Stadecker, “Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17,” Journal of Immunology, vol. 175, no. 6, pp. 3920–3926, 2005. View at Google Scholar · View at Scopus
  61. L. I. Rutitzky and M. J. Stadecker, “CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis,” Memorias do Instituto Oswaldo Cruz, vol. 101, no. 1, pp. 327–330, 2006. View at Google Scholar · View at Scopus
  62. J. K. Mwatha, G. Kimani, T. Kamau et al., “High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni,” Journal of Immunology, vol. 160, no. 4, pp. 1992–1999, 1998. View at Google Scholar · View at Scopus
  63. K. F. Hoffmann, P. Caspar, A. W. Cheever, and T. A. Wynn, “IFN-γ, IL-12, and TNF-α are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12,” Journal of Immunology, vol. 161, no. 8, pp. 4201–4210, 1998. View at Google Scholar · View at Scopus
  64. J.-Y. Zhang, Z.-S. Zou, A. Huang et al., “Hyper-activated pro-inflammatory CD16+ monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B,” PLoS ONE, vol. 6, no. 3, Article ID e17484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. H. W. Zimmermann and F. Tacke, “Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis,” Inflammation and Allergy, vol. 10, no. 6, pp. 509–536, 2011. View at Google Scholar · View at Scopus
  66. J. A. Fallowfield, M. Mizuno, T. J. Kendall et al., “Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis,” Journal of Immunology, vol. 178, no. 8, pp. 5288–5295, 2007. View at Google Scholar · View at Scopus
  67. T. A. Wynn, A. W. Cheever, D. Jankovic et al., “An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection,” Nature, vol. 376, no. 6541, pp. 594–596, 1995. View at Google Scholar · View at Scopus
  68. T. A. Wynn, I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher, “Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology,” Journal of Experimental Medicine, vol. 179, no. 5, pp. 1551–1561, 1994. View at Google Scholar · View at Scopus
  69. M. M. Mentinkkane, A. W. Cheever, M. S. Wilson et al., “Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2,” Gastroenterology, vol. 141, no. 6, pp. 2200–2209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. K. F. Hoffmann, A. W. Cheever, and T. A. Wynn, “IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis,” Journal of Immunology, vol. 164, no. 12, pp. 6406–6416, 2000. View at Google Scholar · View at Scopus
  71. D. R. Herbert, T. Orekov, C. Perkins, and F. D. Finkelman, “IL-10 and TGF-β redundantly protect against severe liver injury and mortality during acute schistosomiasis,” Journal of Immunology, vol. 181, no. 10, pp. 7214–7220, 2008. View at Google Scholar · View at Scopus
  72. L. S. Cardoso, S. Barreto Ade, J. S. Fernandes et al., “Impaired lymphocyte profile in schistosomiasis patients with periportal fibrosis,” Clinical and Developmental Immunology, vol. 2013, Article ID 710647, 2013. View at Publisher · View at Google Scholar